Cue Biopharma Inc stock is traded at $18.01, with a volume of 141,747. It is down -9.22% in the last 24 hours and down -22.17% over the past month. Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
Previous Close:
$19.84
Open:
$19.35
24h Volume:
141,747
Relative Volume:
1.07
Market Cap:
$130.83M
Revenue:
$32.73M
Net Income/Loss:
-$19.52M
P/E Ratio:
-
EPS:
-$5.53
Net Cash Flow:
-$24.61M
1W Performance:
-13.70%
1M Performance:
-22.17%
6M Performance:
-47.00%
1Y Performance:
-16.14%
1-Day Range:
$0.00$0.00
1-Week Range:
$16.87$21.40
52-Week Range:
$4.97$45.50
Cue Biopharma Inc Stock (CUE) Company Profile
Name
Cue Biopharma IncSector
HealthcareIndustry
BiotechnologyPhone
617-949-2680Address
40 GUEST STREET, BOSTON, MA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS